Real-time enrollment status for this pulmonary hypertension associated with hfpef clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:45 AM UTC
| NCT Number | NCT07288398 |
| Recruiting Status | Recruiting |
| Condition | Pulmonary Hypertension Associated With HFpEF |
| Phase | Clinical Trial |
| Target Enrollment | 540 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Tenax Therapeutics, Inc. |
| Last Updated on CT.gov | March 16, 2026 (Mar 16, 2026) |
As of July 13, 2026: Clinical trial NCT07288398 is currently recruiting participants. This clinical trial study for pulmonary hypertension associated with hfpef is actively seeking new participants at 18 locations across the United States. The study is sponsored by Tenax Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07288398 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07288398 was last updated Mar 16, 2026 (March 16, 2026). HelloStudys verifies this status automatically.